Cancer

October 29, 2014

Key to prostate cancer resistance

A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer.

By VUMC News and Communications
October 28, 2014

Improving breast cancer chemo by testing tumors in a dish

A team of biomedical engineers has developed a new “tumor-in-a-dish” technology that promises to improve the effectiveness of chemotherapy.

By VUMC News and Communications
October 16, 2014

Indiana couple hits the links to support melanoma research

A Vanderbilt-Ingram Cancer Center (VICC) melanoma patient is using his passion for golf to support melanoma research efforts at VICC.

By VUMC News and Communications
red laser beam
October 1, 2014

Optical imaging in drug therapy screens

A non-invasive imaging tool could test potential cancer therapies quickly to personalize therapy for patients.

By VUMC News and Communications
lungs
September 24, 2014

Study finds accuracy of lung cancer imaging varies by region

A new analysis of published studies found that FDG-PET technology is less accurate in diagnosing lung cancer versus benign disease in regions where infections like histoplasmosis or tuberculosis are common.

By VUMC News and Communications
September 18, 2014

Grant spurs lung cancer surgery research

Joe B. (Bill) Putnam Jr., M.D., Ingram Professor of Cancer Research and chair of the Department of Thoracic Surgery, and colleague Felix Fernandez, M.D., assistant professor of Surgery, Emory University School of Medicine, Atlanta, have received a grant to investigate the most effective forms of surgery to treat lung cancer patients.

By VUMC News and Communications
September 18, 2014

Predators support powers pediatric cancer programs

The Nashville Predators Foundation recently presented a $318,242 check to Monroe Carell Jr. Children’s Hospital at Vanderbilt for the 365 Pediatric Cancer Fund.
By Christina Echegaray
September 11, 2014

Skin cancer risks higher for soldiers serving abroad

Soldiers deployed to tropical and sunny climates are coming home with increased risk factors for a threat far from the battlefield: skin cancer.
By Wayne Wood
September 4, 2014

Lung cancer study reveals new drug combination targets

A Vanderbilt lung cancer patient’s exceptional response to different types of therapies spurred research that suggests lung cancer patients with specific gene alterations may benefit from combination therapy that targets two different cancer pathways.
By VUMC News and Communications
September 3, 2014

Aggressive bone cancers build more blood vessels

A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options.
By Katherine Venmar
August 28, 2014

Limiting breast cancer metastasis

Vanderbilt researchers have identified a new target for blocking breast cancer metastasis.
By Brandon Turner
August 21, 2014

Study in East Asians identifies genes tied to colon cancer risk

Colorectal cancer is one of the leading causes of death among populations around the world. While diet, physical activity and other lifestyle factors can influence the risk of developing the disease, hereditary factors also play an important role.
By VUMC News and Communications
August 14, 2014

Growth factor blockade targets breast tumors

Inhibition of BMP growth factor signaling reduces breast tumor burden and metastasis.
By VUMC News and Communications